Lataa...
Role of MetMAb (OA-5D5) in c-MET active lung malignancies
INTRODUCTION: MetMAb (OA-5D5) is a one-armed monoclonal antibody developed to bind to and inhibit c-MET receptor tyrosine kinase. Though early in clinical testing, this agent holds great promise in diseases thought to be driven by c-MET activation, as evidenced by the phase II results in non-small c...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3258451/ https://ncbi.nlm.nih.gov/pubmed/22047509 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2011.626762 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|